Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2009-03-30 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75013), Paris
SELARL PHARMARCIE LARTIGOT : revenue, balance sheet and financial ratios
SELARL PHARMARCIE LARTIGOT is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75013),
this company of category PME
shows in 2016 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMARCIE LARTIGOT (SIREN 511710667)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 739 414 €
1 695 130 €
Net income
-501 002 €
70 069 €
82 569 €
78 580 €
66 904 €
119 070 €
105 233 €
57 038 €
81 620 €
78 333 €
62 449 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
156 865 €
138 973 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4.5%
3.7%
Revenue and income statement
In 2025, SELARL PHARMARCIE LARTIGOT records a net loss of 501 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-501 002 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 64%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
63.565%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
592.344
398.413
287.753
226.528
153.359
109.63
112.103
87.45
58.731
39.686
63.565
Financial autonomy
12.734
17.51
22.944
26.429
33.505
40.103
41.394
46.472
54.555
58.719
47.643
Repayment capacity
16.495
11.672
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
4.235%
5.397%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
63.562025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+9 pts over 3 years
In 2025, the debt ratio of SELARL PHARMARCIE LARTIGOT (63.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.64%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average-15 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMARCIE LARTIGOT (47.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 450.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
52.621
58.565
54.917
56.386
50.773
61.087
127.596
113.806
69.567
53.329
450.445
Interest coverage
32.52
21.54
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
450.442025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+61 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMARCIE LARTIGOT (450.44) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMARCIE LARTIGOT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
41 938 €
70 394 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
18
20
0
0
0
0
0
0
0
0
0
Customer payment term (days)
2
3
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
34
39
0
0
0
0
0
0
0
0
0
Positioning of SELARL PHARMARCIE LARTIGOT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMARCIE LARTIGOT with other companies in the same sector:
Frequently asked questions about SELARL PHARMARCIE LARTIGOT
What is the revenue of SELARL PHARMARCIE LARTIGOT ?
The revenue of SELARL PHARMARCIE LARTIGOT in 2016 is 1.7 M€.
Is SELARL PHARMARCIE LARTIGOT profitable?
SELARL PHARMARCIE LARTIGOT recorded a net loss in 2025.
Where is the headquarters of SELARL PHARMARCIE LARTIGOT ?
The headquarters of SELARL PHARMARCIE LARTIGOT is located in PARIS (75013), in the department Paris.
Where to find the tax return of SELARL PHARMARCIE LARTIGOT ?
The tax return of SELARL PHARMARCIE LARTIGOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMARCIE LARTIGOT operate?
SELARL PHARMARCIE LARTIGOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart